Montaye M, De Bacquer D, De Backer G, Amouyel P
INSERM U 508, Institut Pasteur de Lille, France.
Eur Heart J. 2000 May;21(10):808-13. doi: 10.1053/euhj.1999.1854.
To evaluate the management of overweight and obesity in coronary artery disease patients in Europe.
The EUROASPIRE Study is a multicentre epidemiological study involving nine European countries. The major cardiovascular risk factors and their management were collected from hospital records and measured at least 6 months after hospitalization during a specific interview. A total of 4863 consecutive records from men and women with coronary artery disease, under 71 years of age, were reviewed. Interviews were obtained for 3569 (73%). Body mass index was computed from height and weight noted in the medical records and measured at interview. Management of overweight and obesity was recorded at interview. At least 6 months after hospitalization, 75% of women and 80% of men were overweight and 33% of women and 23% of men were obese. Height noted in medical records was over-estimated, inducing an under-estimation of obesity in 16% of men and 33% of women. Advice from a nutritionist was offered in less than 20% of obese patients. The same trends were observed in all participating countries.
Prevalences of overweight and obesity are high in coronary artery disease patients in Europe. A systematic measurement of height and weight is a prerequisite to a better management of this common modifiable risk factor.
评估欧洲冠心病患者超重和肥胖的管理情况。
EUROASPIRE研究是一项涉及九个欧洲国家的多中心流行病学研究。主要心血管危险因素及其管理情况通过医院记录收集,并在特定访谈中于住院至少6个月后进行测量。对4863例年龄在71岁以下的冠心病男女患者的连续记录进行了审查。获得了3569例(73%)患者的访谈资料。根据病历中记录的身高和体重计算体重指数,并在访谈时进行测量。在访谈中记录超重和肥胖的管理情况。住院至少6个月后,75%的女性和80%的男性超重,33%的女性和23%的男性肥胖。病历中记录的身高被高估,导致16%的男性和33%的女性肥胖被低估。不到20%的肥胖患者得到了营养师的建议。所有参与国家均观察到相同趋势。
欧洲冠心病患者超重和肥胖的患病率很高。系统测量身高和体重是更好管理这一常见可改变危险因素的前提条件。